1. Home
  2. EVI vs DCTH Comparison

EVI vs DCTH Comparison

Compare EVI & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVI
  • DCTH
  • Stock Information
  • Founded
  • EVI 1959
  • DCTH 1988
  • Country
  • EVI United States
  • DCTH United States
  • Employees
  • EVI N/A
  • DCTH N/A
  • Industry
  • EVI Other Consumer Services
  • DCTH Medical/Dental Instruments
  • Sector
  • EVI Consumer Discretionary
  • DCTH Health Care
  • Exchange
  • EVI Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • EVI 353.9M
  • DCTH 394.9M
  • IPO Year
  • EVI N/A
  • DCTH N/A
  • Fundamental
  • Price
  • EVI $27.53
  • DCTH $10.94
  • Analyst Decision
  • EVI Strong Buy
  • DCTH Strong Buy
  • Analyst Count
  • EVI 1
  • DCTH 4
  • Target Price
  • EVI $28.00
  • DCTH $24.50
  • AVG Volume (30 Days)
  • EVI 11.1K
  • DCTH 819.3K
  • Earning Date
  • EVI 09-11-2025
  • DCTH 08-06-2025
  • Dividend Yield
  • EVI 1.14%
  • DCTH N/A
  • EPS Growth
  • EVI 29.85
  • DCTH N/A
  • EPS
  • EVI 0.48
  • DCTH 0.06
  • Revenue
  • EVI $370,020,000.00
  • DCTH $70,240,000.00
  • Revenue This Year
  • EVI $10.08
  • DCTH $159.22
  • Revenue Next Year
  • EVI $13.58
  • DCTH $41.22
  • P/E Ratio
  • EVI $56.55
  • DCTH $196.43
  • Revenue Growth
  • EVI 3.51
  • DCTH 491.35
  • 52 Week Low
  • EVI $14.99
  • DCTH $8.08
  • 52 Week High
  • EVI $27.74
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • EVI 64.04
  • DCTH 48.74
  • Support Level
  • EVI $26.58
  • DCTH $10.06
  • Resistance Level
  • EVI $26.00
  • DCTH $11.31
  • Average True Range (ATR)
  • EVI 1.27
  • DCTH 0.48
  • MACD
  • EVI 0.35
  • DCTH 0.15
  • Stochastic Oscillator
  • EVI 96.42
  • DCTH 72.30

About EVI EVI Industries Inc.

EVI Industries Inc through its subsidiaries, is a distributor that sells, leases, and rents commercial, industrial, and vended laundry and dry cleaning equipment and steam and hot water boilers manufactured by others, supplies related replacement parts and accessories, designs and plans turn-key laundry, dry cleaning, and boiler systems, and provides installation and maintenance services to its customers, which include commercial, industrial, institutional, government, and retail customers. These activities are conducted in the United States, Canada, the Caribbean, and Latin America.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: